Breaking News, Collaborations & Alliances

Catalent, Coster in pMDI Development Pact

New line will be part of Catalent's Inhalation CoE

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Coster has signed an agreement with Catalent Pharma Solutions for the development of a line designed for filling pMDIs (pressurized Metered Dose Inhalers). The high-output line will be part of Catalent’s Inhalation Center of Excellence in Research Triangle Park, NC.   The filling line will incorporate Coster’s technology and will have a capacity of 150 cans per minute. The new line is part of Catalent’s $20 million investment at the site and expands existing capabilities. The m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters